{"result": "(\"entity\"<|>HIPÓFISIS<|>GEO<|>Hipófisis is a gland in the endocrine system that plays a crucial role in hormone regulation and is mentioned in the context of medical treatment.)\n##\n(\"entity\"<|>HIPOALDOSTERONISMO<|>EVENT<|>Hiperaldosteronismo is a medical condition characterized by excessive aldosterone production, discussed in the context of treatment options.)\n##\n(\"entity\"<|>HORMONA ANTIDIURÉTICA<|>EVENT<|>Hormona antidiurética (ADH) is a hormone involved in water retention and is relevant to the discussion of SIADH and its treatment.)\n##\n(\"entity\"<|>CLNa<|>EVENT<|>ClNa (Sodium Chloride) is a saline solution mentioned as a treatment for severe hyponatremia in the context of medical management.)\n##\n(\"entity\"<|>NATREMIA<|>EVENT<|>Natremia refers to the concentration of sodium in the blood, which is a key focus in the treatment of conditions like SIADH and hyperaldosteronism.)\n##\n(\"relationship\"<|>HIPÓFISIS<|>HORMONA ANTIDIURÉTICA<|>The hipófisis produces the hormona antidiurética, indicating a direct relationship between the gland and the hormone<|>8)\n##\n(\"relationship\"<|>HIPOALDOSTERONISMO<|>TOLVAPTÁN<|>Tolvaptán can be used in the treatment of hiperaldosteronismo, indicating a relationship between the drug and the condition<|>6)\n##\n(\"relationship\"<|>NATREMIA<|>CLNa<|>ClNa is administered to elevate natremia in cases of severe hyponatremia, indicating a direct relationship between the treatment and the condition<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: incluye                                              El tolvaptán es un antagonista selectivo de los receptores V2 de la vasopresina en el túbulo\n        tiazidas, amilorida y AINE (indometacina o ibuprofeno).                                                                              colector de la nefrona, que induce acuaresis (eliminación                          de agua libre, sin excreción de\n        El tratamiento del hiperaldosteronismo tampoco incluye la restricción hídrica, ya que el hipe-                                       sodio) y     aumenta la natremia.           Se utiliza habitualmente en el SIADH leve-moderado, tras\n        raldosteronismo es principalmente un problema de retención excesiva de sodio, no un proble-                                          fracaso de la restricción hídrica. Es importante suspender la restricción hídrica al paciente\n        ma en la regulación del agua corporal. El objetivo es tratar el exceso de mineralcorticoides y                                       cuando inicia tolvaptán. El paciente debe tener acceso libre al agua porque si la acuaresis\n        puede hacerse quirúrgicamente cuando esté indicado (en caso de adenomas único productor                                              es importante y produce sed, pero el paciente no tiene acceso libre al agua, podría producir-\n        de aldosterona o de hiperplasia única) o médicamente (con antagonistas del receptor de mine-                                         se una elevación demasiado rápida del sodio (respuesta C falsa).\n        ralcorticoides o con glucocorticoides en el hiperaldosteronismo sensible a glucocorticoides).                                        En pacientes con hiponatremia grave sintomática (con convulsiones, bajo nivel de conscien-\n        Referencias:                                                                                                                         cia o coma) el tratamiento de elección y el único modo de elevar rápidamente la natremia, así\n        •  Lahera Vargas M. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015.  como de mejorar la clínica neurológica, es administrar un bolo intravenoso de 100 ml de suero\n           Capítulo 34. Hiperaldosteronismo primario [citado 29 de abril de 2019]. Disponible en: https://manual.seen.es/article?id=\n           55114c6f-2b74-4e4a-bd36-2bcdac18103c                                                                                              hipertónico al 3%, que elevará la natremia 1,5 mEq/l en varones y 2 mEq/l en mujeres. Si no se\n        •  Páramo Fernández C. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición;     logra mejoría sintomática, se podría repetir la administración del bolo (respuesta D correcta).\n           2015. Capítulo 19. Diabetes insípida [citado 29 de abril de 2019]. Disponible en: https://manual.seen.es/article?id=55114b-\n           cb-1d84-4d32-acb4-2bcdac18103c\n        •  Villabona C. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015.      Referencias:\n           Capítulo 20. Síndrome de secreción inapropiada de la hormona antidiurética (SIADH); [citado 29 de abril de 2019]. Disponible en:  • Sterns RH. Treatment of hiponatremia: Syndrome of inappropiate antidiuretic hormone secretion (SIADH) and reset osmostat.\n           https://manual.seen.es/article?id=55114bd4-c9f0-42b4-ac84-2bcdac18103c                                                              En: Emmett M, Forman JP, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso 29 de abril de 2019).\n                                                                                                                                             • Villabona C. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015.\n                                                                                                                                               Capítulo 20. Síndrome de secreción inapropiada de la hormona antidiurética (SIADH) [citado 29 de abril de 2019]. Disponible en:\n                                                                                                                                               https://manual.seen.es/article?id=55114bd4-c9f0-42b4-ac84-2bcdac18103c\n    56  Indique qué es verdad en el SIADH:\n        A. La osmolalidad urinaria es superior a la osmolalidad plasmática.\n        B. La respuesta a la restricción de fluidos es independiente del volumen urinario.\n        C. Al inicio de la toma de tolvaptán se aconseja que no ingieran agua.\n        D.   En una situación aguda en coma y con convulsiones está indicado la administración\n             de 100 ml de ClNa al 3% y repetir en 30 min si no se produce mejoría clínica.\n\n\n\n68                                                                                                                                                                                                                                                                             69\n---\n                                                                                                                                                                                                       HIPÓFISIS                         1\n\n\n\n    57  ¿Cu\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>TOLVAPTÁN<|>ORGANIZATION<|>Tolvaptán is a selective V2 vasopressin receptor antagonist used in the treatment of conditions like SIADH and hyperaldosteronism.)\n##\n(\"entity\"<|>LAHERA VARGAS M<|>PERSON<|>Lahera Vargas M. is an author of a manual on endocrinology and nutrition, providing references for medical treatments.)\n##\n(\"entity\"<|>PÁRAMO FERNÁNDEZ C<|>PERSON<|>Páramo Fernández C. is an author of a manual on endocrinology and nutrition, providing references for medical treatments.)\n##\n(\"entity\"<|>VILLABONA C<|>PERSON<|>Villabona C. is an author of a manual on endocrinology and nutrition, providing references for medical treatments.)\n##\n(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición is an organization that publishes manuals and guidelines in the field of endocrinology and nutrition.)\n##\n(\"entity\"<|>SIADH<|>EVENT<|>SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion) is a medical condition discussed in the context of treatment and management in the provided text.)\n##\n(\"relationship\"<|>TOLVAPTÁN<|>SIADH<|>Tolvaptán is used as a treatment for SIADH, indicating a direct relationship between the drug and the condition<|>8)\n##\n(\"relationship\"<|>LAHERA VARGAS M<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Lahera Vargas M. authored a manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>PÁRAMO FERNÁNDEZ C<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Páramo Fernández C. authored a manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>VILLABONA C<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Villabona C. authored a manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n<|COMPLETE|>"}]}